Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Gilbert

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|January 17, 2002
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromesR E Gilbert
Diabetes & Metabolism|January 3, 2015
SGLT-2 inhibition in patients with kidney diseaseR E Gilbert
The Medical Journal of Australia|November 21, 1994
Angiotensin converting enzyme inhibitors and diabetic renal disease. ACE inhibitors may prevent progression from incipient to clinical nephropathyR E Gilbert, G Jerums
The British Journal of Ophthalmology|February 3, 2000
Is ocular toxoplasmosis caused by prenatal or postnatal infection?R E Gilbert, M R Stanford
BMJ (Clinical Research Ed.)|August 24, 1999
Perinatal mortality and morbidity among babies delivered in water: surveillance study and postal surveyR E Gilbert, P A Tookey
Journal of Medical Screening|October 9, 2002
Congenital toxoplasmosis in the United Kingdom: to screen or not to screen?R E Gilbert, C S Peckham
Kidney International|November 26, 1999
The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?R E Gilbert, M E Cooper
Memorias Do Instituto Oswaldo Cruz|May 12, 2009
Treating ocular toxoplasmosis: current evidenceM R Stanford, R E Gilbert
Current Hypertension Reports|April 21, 2015
Are SGLT2 inhibitors reasonable antihypertensive drugs and renoprotective?J A Lovshin, R E Gilbert
Australian and New Zealand Journal of Medicine|August 1, 1992
Semi-quantitative determination of microalbuminuria by urinary dipstickR E Gilbert, A Akdeniz, G Jerums
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|January 17, 2002
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromesR E Gilbert
Diabetes & Metabolism|January 3, 2015
SGLT-2 inhibition in patients with kidney diseaseR E Gilbert
The Medical Journal of Australia|November 21, 1994
Angiotensin converting enzyme inhibitors and diabetic renal disease. ACE inhibitors may prevent progression from incipient to clinical nephropathyR E Gilbert, G Jerums
The British Journal of Ophthalmology|February 3, 2000
Is ocular toxoplasmosis caused by prenatal or postnatal infection?R E Gilbert, M R Stanford
BMJ (Clinical Research Ed.)|August 24, 1999
Perinatal mortality and morbidity among babies delivered in water: surveillance study and postal surveyR E Gilbert, P A Tookey
Journal of Medical Screening|October 9, 2002
Congenital toxoplasmosis in the United Kingdom: to screen or not to screen?R E Gilbert, C S Peckham
Kidney International|November 26, 1999
The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?R E Gilbert, M E Cooper
Memorias Do Instituto Oswaldo Cruz|May 12, 2009
Treating ocular toxoplasmosis: current evidenceM R Stanford, R E Gilbert
Current Hypertension Reports|April 21, 2015
Are SGLT2 inhibitors reasonable antihypertensive drugs and renoprotective?J A Lovshin, R E Gilbert
Australian and New Zealand Journal of Medicine|August 1, 1992
Semi-quantitative determination of microalbuminuria by urinary dipstickR E Gilbert, A Akdeniz, G Jerums
Pageof 13